The global drug-eluting stent market is poised for significant growth, reaching an estimated USD 14.98 billion by 2031. This represents a substantial increase from the USD 7.80 billion market size recorded in 2023, with a projected Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period of 2024-2031.
Key Players
The major key players are Abbott Laboratories, Boston Scientific Corporation, Medtronic, Cordis Corporation (a Johnson & Johnson company), Terumo Corporation, Biosensors International Group, Ltd, Biotronik SE & Co. KG, St. Jude Medical, Inc. and others.
Market Scope and Analysis
This press release sheds light on the key drivers and trends shaping the DES market:
- Market Definition and Segmentation: A clear explanation of DES technology and its role in treating narrowed arteries. The report further segments the market by product type, material, application (coronary artery disease vs. peripheral artery disease), and end-user.
- Market Drivers: Identification of the major factors propelling market expansion, such as the growing prevalence of cardiovascular diseases (CVD), increasing adoption of minimally invasive procedures, and technological advancements in DES design and drug delivery.
- Challenges and Opportunities: Exploration of potential hurdles like high healthcare costs and stringent regulatory processes, alongside emerging opportunities presented by bioabsorbable stents and advancements in drug coatings.
KEY SEGMENTS
By Type
- Coronary Stenting
- Peripheral Stenting
By Scaffold
- Cobalt-Chromium
- Platinum-Chromium
- Nitinol
- Others
By Drug
- Sirolimus
- Paclitaxel
- Zotarolimus
- Everolimus
- Others
By End User
- Hospitals
- Specialty Clinics
Impact of Global Events
The press release examines the potential influence of current events on the market:
- Russia-Ukraine Conflict: The conflict’s impact on the global supply chain for DES components and potential disruptions in research and development activities.
- Economic Slowdown: The potential effect of a global economic downturn on healthcare spending and patient access to DES procedures.
Regional Analysis
The press release offers a breakdown of the market across key geographic regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. It highlights the growth prospects and specific dynamics within each region, considering factors like healthcare infrastructure development and prevalence of CVD.
Key Takeaways and Recent Developments
- The press release summarizes the most critical findings from the market analysis, providing valuable information for stakeholders.
- It also spotlights recent advancements in DES technology, such as the development of next-generation stents with improved biocompatibility and reduced long-term complications.
This press release serves as a valuable resource for:
- Medical device companies developing and manufacturing DES
- Investors seeking market insights for informed decision-making
- Healthcare providers and institutions treating patients with CVD
- Researchers and scientists working on DES innovation
Other Trending Report
Vagus Nerve Stimulation Market Share
Rotator Cuff Injury Treatment Market Share
Self-supervised Learning Market Share
Stomach Cancer Treatment Market Share
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com
